Previous data obtained in human glioblastoma cells showed that the activation of the M2 muscarinic receptor, with agonist molecules, dramatically reduced the proliferative rate and cell survival of cancer cells, exhibiting cytotoxic effects 7–10 and mitochondrial defects (unpublished results). Here, CHRM2 is linked to glioblastoma.